
Emerging From the Pandemic: Pompe Perspectives
Dr Aneal Khan, Alexandra Butler, Sherry Simo and Lochlan Smyth will recap and look forward to emerging from the pandemic.
Dr Aneal Khan, Alexandra Butler, Sherry Simo and Lochlan Smyth will recap and look forward to emerging from the pandemic.
A Q&A with Dr Aneal Khan, MSc, MD, FRCPC, FCCMG; Professor of Medical Genetics and Pediatrics, University of Calgary, Alberta Children’s Hospital.
At this time, Sanofi Genzyme does not anticipate shortages for patients resulting from the COVID-19 situation.
Patients enrolled in all clinical studies for AT-GAA for Pompe disease, including the PROPEL pivotal study, will continue to receive study drug.